SeaCrest Wealth Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-609
Closed -$123K – 1110
2022
Q2
$123K Buy
+609
New +$130K 0.02% 777
2022
Q1
– Sell
-790
Closed -$213K – 743
2021
Q4
$213K Buy
+790
New +$196K 0.02% 623
2020
Q3
– Sell
-2,919
Closed -$417K – 604
2020
Q2
$417K Sell
2,919
-142
-5% -$19.6K 0.07% 288
2020
Q1
$332K Buy
+3,061
New +$441K 0.07% 301
2019
Q2
– Sell
-487
Closed -$64K – 1254
2019
Q1
$64K Buy
487
+28
+6% +$3.45K 0.01% 849
2018
Q4
$50K Buy
459
+75
+20% +$10K 0.01% 894
2018
Q3
$57K Buy
384
+14
+4% +$2.13K 0.01% 941
2018
Q2
$57K Buy
370
+105
+40% +$15.8K 0.01% 928
2018
Q1
$37K Buy
265
+95
+56% +$14K 0.01% 1078
2017
Q4
$23K Buy
+170
New +$22.5K ﹤0.01% 1287

Other funds holding LH

SeaCrest Wealth Management's LH Position: Q3 2022 in Review

SeaCrest Wealth Management sold out of Labcorp (LH) in Q3 2022, closing a stake of 609 shares — an estimated $123K sold.

SeaCrest Wealth Management first reported a position in LH in Q4 2017 and held it in 10 quarters. The position peaked at $417K in Q2 2020. 936 funds tracked by Wall St. Rank hold LH as of Q3 2022.

  • SeaCrest Wealth Management reported no remaining Labcorp position as of Q3 2022 after selling out during the quarter.
  • SeaCrest Wealth Management sold 609 Labcorp shares in Q3 2022, an estimated $123K.
  • SeaCrest Wealth Management first reported a position in Labcorp in Q4 2017 and held it in 10 quarters.
  • SeaCrest Wealth Management's Labcorp position peaked at $417K in Q2 2020.
  • 936 funds tracked by Wall St. Rank held Labcorp as of Q3 2022.

Based on SeaCrest Wealth Management's 13F filing for Q3 2022, filed 15 Nov 2022.